FormDPulse / report

Nuclein, LLC raised $15,650,488 (Austin, TX)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 01:28:40 GMT

Nuclein, LLC plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

63 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $313,010 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $15,650,488 so far.
  • Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
FieldValue
IndustryBiotechnology (Healthcare & Life Sciences)
Operating companyYes
Exemption506(b)
Amount sold$15,650,488
Total offering$26,114,842
Investors so far25
First sale2026-06-04
Filed2026-10-27 (amendment)
EntityLimited Liability Company

Executives and related persons (from the filing)

  • Alan Blake: Executive Officer, Director
  • Richard Crockett: Director
  • William Cunningham: Director
  • Douglas Bryant: Director
  • Sanjay Chandra: Director
  • H. David Shockley: Director
  • Walter Narajowski: Director
  • Jeffrey Stukuls: Executive Officer

View the filing on SEC EDGAR

Markdown version

Nuclein, LLC vs. top 3 peers

OrganizationLocationCapital raisedRecord date
Nuclein, LLCAustin$15,650,4882026-10-27
XRHealth, Inc.Needham$16,253,0292026-10-23
Trellis Bioscience, Inc.Redwood City$9,093,0002026-10-29
Septal Solutions, Inc.Exton$7,319,6952026-10-27

Related records

Newly funded companies in Texas (SEC Form D) Newly funded Healthcare & Life Sciences companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.